Stool-Based Biomarkers to Differentiate Between IBD and IBS

What are IBD and IBS? Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are two different gastrointestinal tract issues Read More…

Early Detection of Diabetic Kidney Disease with Biomarkers

Introduction Over one third of diabetics will develop diabetic kidney disease (DKD) in their lifetime1. Despite the large amount of Read More…

GeneTex’s KO/KD-Validated QKI Antibodies for Neuroscience Research

QUAKING/QKI belongs to the STAR (Signal Transducer and Activator of RNA) family of RNA-binding proteins and functions in the differentiation Read More…

Investigating Bioactive Leptin in Obesity Research

The Biology of Leptin Leptin is a hormone composed of 167 amino acids and is primarily produced by adipocytes, therefore Read More…

Developing A Chemiluminescent Immunoassay Platform

Introduction ALPCO developed STELLUX® as a chemiluminescent immunoassay platform aimed at detecting key biomarkers in the life science research and Read More…

The Changing Roles of Bone Remodeling Biomarkers

Introduction Bones are traditionally known for their support, protection and movement properties, as well as their role in the processes Read More…

Emerging Biomarker Research in NAFLD and NASH

Nonalcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease in the western hemisphere affecting 1 in Read More…

Obesity Induced Adipose Tissue Dysfunction and NAFLD

Obesity is a known risk factor for developing metabolic diseases such as non-alcoholic fatty liver disease (NAFLD)1. An increasing amount Read More…

Classes of Biologics for the Treatment of IBD

Monoclonal antibody (mAb) biologics have been used to treat inflammatory bowel disease (IBD) for several years. Various classes of biologics Read More…

Researching Therapeutic Drug Monitoring for IBD

Multiple classes of biologics are available for the treatment of inflammation associated with inflammatory bowel disease (IBD) which ultimately improves Read More…

Therapeutic Drug Monitoring of Biosimilars in Autoimmune Diseases

Anti-TNF-alpha biologics have been proven to be effective treatments for autoimmune diseases such as rheumatoid arthritis (RA) and inflammatory bowel Read More…

Challenges When Treating IBD with Biologics

Monoclonal antibody (mAbs) biologics have been used to treat inflammatory bowel disease (IBD) for 20 years1. Despite the successful use Read More…